ENTRY       K10151                      KO
NAME        CCND2
DEFINITION  cyclin D2
PATHWAY     ko04068  FoxO signaling pathway
            ko04110  Cell cycle
            ko04115  p53 signaling pathway
            ko04151  PI3K-Akt signaling pathway
            ko04310  Wnt signaling pathway
            ko04390  Hippo signaling pathway
            ko04510  Focal adhesion
            ko04630  Jak-STAT signaling pathway
            ko04917  Prolactin signaling pathway
            ko05162  Measles
            ko05166  HTLV-I infection
            ko05202  Transcriptional misregulation in cancer
            ko05203  Viral carcinogenesis
            ko05206  MicroRNAs in cancer
DISEASE     H00023  Testicular cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04310 Wnt signaling pathway
                K10151  CCND2; cyclin D2
               04390 Hippo signaling pathway
                K10151  CCND2; cyclin D2
               04630 Jak-STAT signaling pathway
                K10151  CCND2; cyclin D2
               04068 FoxO signaling pathway
                K10151  CCND2; cyclin D2
               04151 PI3K-Akt signaling pathway
                K10151  CCND2; cyclin D2
             Cellular Processes
              Cell growth and death
               04110 Cell cycle
                K10151  CCND2; cyclin D2
               04115 p53 signaling pathway
                K10151  CCND2; cyclin D2
              Cell communication
               04510 Focal adhesion
                K10151  CCND2; cyclin D2
             Organismal Systems
              Endocrine system
               04917 Prolactin signaling pathway
                K10151  CCND2; cyclin D2
             Human Diseases
              Cancers
               05202 Transcriptional misregulation in cancers
                K10151  CCND2; cyclin D2
               05206 MicroRNAs in cancer
                K10151  CCND2; cyclin D2
               05203 Viral carcinogenesis
                K10151  CCND2; cyclin D2
              Infectious diseases
               05166 HTLV-I infection
                K10151  CCND2; cyclin D2
               05162 Measles
                K10151  CCND2; cyclin D2
GENES       HSA: 894(CCND2)
            PTR: 747123(CCND2)
            PPS: 100990850(CCND2)
            GGO: 101139749(CCND2)
            PON: 100457978(CCND2)
            MCC: 710379(CCND2)
            MCF: 102119572(CCND2)
            MMU: 12444(Ccnd2)
            RNO: 64033(Ccnd2)
            CGE: 100771544(Ccnd2)
            HGL: 101721480(Ccnd2)
            TUP: 102479902(CCND2)
            CFA: 611782(CCND2)
            AML: 100471517
            FCA: 101090950(CCND2)
            PTG: 102970259(CCND2)
            BTA: 615414(CCND2)
            BOM: 102272576(CCND2)
            PHD: 102326040(CCND2)
            CHX: 102180657(CCND2)
            SSC: 397162(CCND2)
            CFR: 102511263(CCND2)
            BACU: 103002964(CCND2)
            LVE: 103077970(CCND2)
            ECB: 100051150(CCND2)
            MYB: 102254218(CCND2)
            MYD: 102755701(CCND2)
            PALE: 102892640(CCND2)
            MDO: 100016259(CCND2)
            SHR: 100915102 100915359(CCND2)
            OAA: 100088940
            GGA: 374047(CCND2)
            MGP: 100550222
            TGU: 100224096(CCND2)
            FAB: 101818224(CCND2)
            PHI: 102114518(CCND2)
            APLA: 101802600(CCND2)
            FPG: 101920354(CCND2)
            FCH: 102053549(CCND2)
            CLV: 102093196(CCND2)
            ASN: 102388617(CCND2)
            AMJ: 102564576(CCND2)
            PSS: 102462674(CCND2)
            CMY: 102931445(CCND2)
            XLA: 373667(ccnd2-a) 734882(ccnd2-b)
            XTR: 100038071(ccnd2)
            DRE: 799608(ccnd2a)
            TRU: 101063905 101073562 101080220
            MZE: 101470118 101472403 101472513 101479984
            OLA: 101163574 101165722 101174910 101175697
            XMA: 102220824 102225733 102230338
            LCM: 102345953 102351286(CCND2) 102367471
            CMK: 103182468(ccnd3) 103185578(ccnd2)
            BFO: BRAFLDRAFT_271951
            CIN: 100186373
            DME: Dmel_CG9096(CycD)
            DER: Dere_GG19360
            DPE: Dper_GL20678
            DSE: Dsec_GM22512
            DSI: Dsim_GD15773
            DWI: Dwil_GK15308
            DYA: Dyak_GE16008
            DGR: Dgri_GH12170
            DMO: Dmoj_GI14224
            DVI: Dvir_GJ14657
            AGA: AgaP_AGAP012299
            AAG: AaeL_AAEL011648
            CQU: CpipJ_CPIJ014520
            AME: 413183(CycD)
            NVI: 100117434(cycD)
            TCA: 660655 663226
            BMOR: 100862781(cycD) 101738852
            API: 100164890 100167546
            PHU: Phum_PHUM009080 Phum_PHUM503450
            CEL: CELE_Y38F1A.5(cyd-1)
            CBR: CBG02768(Cbr-cyd-1)
            BMY: Bm1_02025
            LOA: LOAG_13310
            NVE: NEMVE_v1g237657
            HMG: 100198325
            TAD: TRIADDRAFT_37409
            TCC: TCM_007869
            GMX: 100798996
            FVE: 101308931
            CSV: 101219121
            POP: POPTR_0001s29970g(POPTRDRAFT_550021A) POPTR_0009s08990g(POPTRDRAFT_804326)
            SMO: SELMODRAFT_420671(CYCD2-1) SELMODRAFT_421971(CYCD2-2)
            PPP: PHYPADRAFT_160648
REFERENCE   PMID:18050422
  AUTHORS   van den Heuvel S
  TITLE     Cell-cycle regulation.
  JOURNAL   WormBook 1-16 (2005)
///
